B. Metzler seel. Sohn & Co’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-2,542
| Closed | -$469K | – | 747 |
|
2024
Q4 | $469K | Buy |
2,542
+1,416
| +126% | +$261K | ﹤0.01% | 652 |
|
2024
Q3 | $222K | Hold |
1,126
| – | – | ﹤0.01% | 742 |
|
2024
Q2 | $233K | Buy |
1,126
+69
| +7% | +$14.3K | ﹤0.01% | 737 |
|
2024
Q1 | $286K | Hold |
1,057
| – | – | ﹤0.01% | 702 |
|
2023
Q4 | $250K | Hold |
1,057
| – | – | ﹤0.01% | 713 |
|
2023
Q3 | $207K | Hold |
1,057
| – | – | ﹤0.01% | 703 |
|
2023
Q2 | $222K | Hold |
1,057
| – | – | ﹤0.01% | 698 |
|
2023
Q1 | $213K | Hold |
1,057
| – | – | ﹤0.01% | 700 |
|
2022
Q4 | $230K | Buy |
+1,057
| New | +$230K | ﹤0.01% | 676 |
|
2022
Q2 | – | Sell |
-789
| Closed | -$224K | – | 730 |
|
2022
Q1 | $224K | Hold |
789
| – | – | ﹤0.01% | 741 |
|
2021
Q4 | $297K | Sell |
789
-1,400
| -64% | -$527K | ﹤0.01% | 643 |
|
2021
Q3 | $903K | Buy |
2,189
+1,400
| +177% | +$578K | 0.01% | 456 |
|
2021
Q2 | $292K | Buy |
+789
| New | +$292K | ﹤0.01% | 627 |
|